Endothelin-1 (ET-1) is a promising biomarker for predicting BPD, as it is associated with bronchoconstriction and pulmonary hypertension, with elevated levels indicating early risk in preterm infants with nRDS (3–5). This evidence concerns the gene EDN1 and pulmonary hypertension.